Cytisin amidophosphate--the new cytoprotector.
Copyright policy )Cytisin amidophosphate--the new cytoprotector.
This article describes the results of a clinical study of O,O dimethyl-N-cytinizylphosphate in healthy volunteers and 142 patients with the verified diagnosis of acute toxic hepatitis. The tolerability was good. The efficiency of the drug is considered to be very high, normalization of the state took less time in comparison with standard treatment; a significant improvement was achieved immediately after the first injection.
- Nazarbayev University Kazakhstan
- Hiroshima University Japan
Adult, Male, Adolescent, 490, 610, Cytoprotector, Middle Aged, Acute toxic hepatitis, Antioxidants, Oxidative Stress, Young Adult, Alkaloids, Organophosphorus Compounds, Treatment Outcome, Cytoprotection, Acute Disease, Humans, Female, Chemical and Drug Induced Liver Injury
Adult, Male, Adolescent, 490, 610, Cytoprotector, Middle Aged, Acute toxic hepatitis, Antioxidants, Oxidative Stress, Young Adult, Alkaloids, Organophosphorus Compounds, Treatment Outcome, Cytoprotection, Acute Disease, Humans, Female, Chemical and Drug Induced Liver Injury
selected citations These citations are derived from selected sources.This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).0 popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.Average influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).Average impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.Average
Citations provided by BIP!Popularity provided by BIP!